-
No matter what size your IRB is, you can move to an electronic process for IRB submissions, reviews, and management.
-
Keeping IRB chairs and members updated and well informed can be challenging when an institution's human subjects research is rapidly expanding.
-
-
As the world faces its first flu pandemic in more than 40 years, researchers say slow, complicated ethics review processes hinder their ability to respond effectively to emerging infectious diseases.
-
Taking steps now to streamline approval processes for fast-moving diseases will better prepare IRBs to handle not just the current H1N1 virus, but future viruses as well, says Raphael Saginur, MD, FRCPC, chief of the infectious disease division and chairman of the research ethics board (REB) at Ottawa Hospital in Ontario.
-
Improving ease of access to potential research data while aggressively protecting identifiable patient information it's a goal that many institutions struggle with.
-
It was clear to IRB coordinators that something had to be done to improve the length of IRB meetings. Some of the four biomedical IRBs at Northwestern University in Chicago, IL, were fairly fast in reviewing protocols, but others took too long.
-
-
In this issue: Clopidogrel and proton pump inhibitors; adverse events with tamsulosin after cataract surgery; new guidelines for persistent pain in the elderly; and FDA Actions.
-
Numerous studies have demonstrated the benefit of an early invasive strategy in patients presenting with non-ST elevation acute coronary syndromes (ACS).
